Search for: "Tom Lamb"
Results 1 - 20
of 1,046
Sort by Relevance
|
Sort by Date
31 Mar 2025, 1:04 pm
Discusses Timing for Increased Risk of Semaglutide-related Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Side Effect (Posted by Tom Lamb at Drug Injury Watch) On March 27, 2025, the JAMA Ophthalmology medical journal published a report about a recent medical study examining the relatively new drug safety issue of vision loss and blindness due to NAION linked to Ozempic and Rybelsus use by patients with type 2 diabetes. [read post]
28 Mar 2025, 3:00 am
National/Federal Paul Weiss Chair Says Deal with Trump Adheres to Firm’s Principles DNyuz – Matthew Goldstein, Jessica Silver-Greenbergm and Ben Protess (New York Times) | Published: 3/21/2025 The chairperson of Paul Weiss sought to reassure employees at the giant law firm that the deal it reached with President Trump was consistent with principles the firm has long stood by. [read post]
21 Feb 2025, 12:43 pm
Or you can call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible Ozempic, Wegovy, or Rybelsus drug injury lawsuit. [read post]
7 Feb 2025, 2:00 pm
(Posted by Tom Lamb at Drug Injury Watch) One of the primary issues in the increasing number of Depo-Provera meningioma lawsuits will likely be why the drug label in the US still does not include a meningioma warning. [read post]
30 Jan 2025, 2:35 pm
While European Union (EU) and United Kingdom (UK) Drug Labels Have Warned About Meningioma for Many Years (Posted by Tom Lamb at Drug Injury Watch) Drug injury lawsuits that involve the contraceptive injection Depo-Provera being linked to brain tumors in some women have been filed against the responsible pharmaceutical companies over the past several months. [read post]
24 Jan 2025, 8:34 am
., Tom Lenard and Scott Wallsten in the Wall Street Journal and the articles contributed by former DOJ Chief Counsel for Economics Greg Werden and former FTC Office of Policy Planning Director Bilal Sayyed to a collection I was privileged to organize recently for Concurrences. [read post]
20 Jan 2025, 12:16 pm
Pix credit hereEach year for the past several years on the anniversary of the birth of the Reverend Dr. [read post]
3 Jan 2025, 2:35 pm
" (Posted by Tom Lamb at Drug Injury Watch) In our November 21, 2024 article, "Do Andexxa Risks Outweigh Benefits Given Increased Rate of Thrombosis and Thrombosis-Related Deaths? [read post]
18 Dec 2024, 2:03 pm
European Drug Regulators Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU review for potential eye disease connection", there is a significant development concerning semaglutide weight-loss drugs like Ozempic linked to vision loss and blindness: The European Union's drug… [read post]
12 Dec 2024, 3:05 pm
New Cases of Liver Transplants And Liver-Related Deaths Among Patients Who Did Not Have Cirrhosis (Posted by Tom Lamb at Drug Injury Watch) In a December 12, 2024, Drug Safety Communication the FDA said it had recently found cases of Ocaliva liver injury among patients who did not yet have cirrhosis, or scarring of the liver, including reports of liver transplants and liver-related deaths. [read post]
Do Andexxa Risks Outweigh Benefits Given Increased Rate of Thrombosis and Thrombosis-Related Deaths?
21 Nov 2024, 12:00 pm
Issue to be Considered by FDA Advisory Committee on November 21, 2024, and Discussion May Lead to Andexxa Drug Recall (Posted by Tom Lamb at Drug Injury Watch) At its November 21, 2024 meeting, the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will discuss whether Andexxa risks outweigh benefits. [read post]
28 Oct 2024, 1:41 pm
Accidents can happen anytime and anywhere, and New York City is no exception. [read post]
16 Oct 2024, 1:44 pm
Intracranial Meningioma Risks Are Increased When Depo-Provera Was Used for More Than One Year (Posted by Tom Lamb at Drug Injury Watch) A medical journal article published in March 2024 reported that Depo-Provera (medroxyprogesterone acetate) increased the risk of intracranial meningioma by 5.6 times if Depo-Provera was used as birth control for longer than a year. [read post]
30 Sep 2024, 11:02 am
Federal Appeals Court Rejects Merck's Legal Defense of Federal Preemption in September 2024 (Posted by Tom Lamb at Drug Injury Watch) A federal appeals court ruled in September 2024 that more than 500 plaintiffs should have their Fosamax femur fracture drug injury lawsuits reinstated and sent back to the current judge presiding over the federal court Fosamax MDL litigation. [read post]
12 Sep 2024, 1:40 pm
August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests (Posted by Tom Lamb at Drug Injury Watch) On September 12, 2024, the FDA announced a warning about the rare occurrence of serious liver injury when a woman is using Veozah for hot flashes due to menopause. [read post]
26 Aug 2024, 9:15 am
Drug Company Apellis Failed to Warn About Retinal Vasculitis Until a November 2023 Label Change (Posted by Tom Lamb at Drug Injury Watch) We are handling Syfovre injections side effects legal compensation cases being filed for patients The basis for these product liability personal injury lawsuits is the drug company Apellis failed to warn about retinal vasculitis until a November 2023 label change. [read post]
18 Jul 2024, 12:53 pm
Growing Number of Pulmonary Embolism and DVT Cases Involving Semaglutide Reported by Patients (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic have been associated with an increased risk of blood clots that can lead to pulmonary embolism (sometimes called PE) and deep vein thrombosis (often called DVT). [read post]
5 Jul 2024, 9:30 am
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or "Eye Stroke", Can Cause Vision Loss (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent finding that the active ingredient of these three drugs semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION). [read post]
28 Jun 2024, 11:45 am
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment when it comes to the US FDA and its European counterpart, the European Medicines Agency (EMA). [read post]
14 May 2024, 2:07 pm
Semaglutide-related Side Effects Include Ischemic Stroke, Pulmonary Embolism, and Deep Vein Thrombosis (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic are drugs with semaglutide as their active ingredient. [read post]
